Article info
PDFHepatology
Original article
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity
- Correspondence to Dr Pere Ginès, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain; pgines{at}clinic.ub.es
Citation
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity
Publication history
- Revised June 28, 2011
- Accepted July 12, 2011
- First published August 11, 2011.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.